All in the family: aldose reductase and closely related aldo-keto reductases.
Level 5 - mechanism / opinion, no new human data
Narrative review synthesizing mechanistic and structural properties of aldose reductase and related enzymes with no primary human trial data.
PubMed 15094999 · doi:10.1007/s00018-003-3402-3
What was done
This narrative review summarizes structural and catalytic properties, signaling roles, and oxidative defense functions of aldose reductase and related members of the aldo-keto reductase enzyme superfamily.
What was found
The abstract reports no quantitative data or empirical metrics. It describes the role of aldose reductase in the polyol pathway and diabetic complications, noting that related aldo-keto reductases share overlapping structural features and enzymatic activities involved in signal processing and oxidative stress responses.
Why it matters
Understanding the broader functional spectrum and structural homology of aldo-keto reductases helps clarify their physiological roles beyond glucose metabolism, informing targeted drug design for diabetic complications.
Limits
The abstract provides no quantitative data, sample details, or systematic search methodology, presenting only generalized narrative conclusions regarding enzyme biology.
Cited by
- context Ruth van Heyningen discovered in the 1950s that aldose reductase is expressed at high levels in organs where diabetic complications occur, including the eyes, nerves, blood vessels, and kidneys.